Genetics Generation Advancement Corp.

TPEX:4160 Stock Report

Market Cap: NT$1.8b

Genetics Generation Advancement Balance Sheet Health

Financial Health criteria checks 5/6

Genetics Generation Advancement has a total shareholder equity of NT$575.1M and total debt of NT$30.0M, which brings its debt-to-equity ratio to 5.2%. Its total assets and total liabilities are NT$759.5M and NT$184.4M respectively. Genetics Generation Advancement's EBIT is NT$55.9M making its interest coverage ratio -11.6. It has cash and short-term investments of NT$424.3M.

Key information

5.2%

Debt to equity ratio

NT$30.00m

Debt

Interest coverage ratio-11.6x
CashNT$424.34m
EquityNT$575.12m
Total liabilitiesNT$184.41m
Total assetsNT$759.54m

Recent financial health updates

No updates

Recent updates

Consider This Before Buying Genetics Generation Advancement Corp. (GTSM:4160) For The 2.8% Dividend

Feb 25
Consider This Before Buying Genetics Generation Advancement Corp. (GTSM:4160) For The 2.8% Dividend

Financial Position Analysis

Short Term Liabilities: 4160's short term assets (NT$591.7M) exceed its short term liabilities (NT$180.0M).

Long Term Liabilities: 4160's short term assets (NT$591.7M) exceed its long term liabilities (NT$4.4M).

Debt to Equity History and Analysis

Debt Level: 4160 has more cash than its total debt.

Reducing Debt: 4160's debt to equity ratio has increased from 0% to 5.2% over the past 5 years.

Debt Coverage: 4160's debt is well covered by operating cash flow (330.2%).

Interest Coverage: 4160 earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 09:49
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genetics Generation Advancement Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Regina LeeJih Sun Securities Investment Consulting Co., Ltd.